Most Recent
Novartis, Pharmacor resolve suit over Gilenya patents
Intellectual Property 2022-11-14 1:42 pm By Cat Fredenburgh

Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Court upholds validity of Pfizer’s Dynastat patent
Intellectual Property 2022-09-30 4:58 pm By Cindy Cameronne

A judge has thrown out competing appeals of a decision finding Pfizer’s patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Lawyers, funder come to blows in Montara oil spill class action
Class Actions 2022-09-07 11:17 pm By Christine Caulfield

A fight has broken out between the litigation funder and the lawyers representing 15,000 seaweed farmers in a class action against oil exploration company PTTEP Australia over a spill at its Montara oil field in the Timor Sea.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bangkok Broadcasting settles ‘7’ trade mark stoush with Seven Network
Intellectual Property 2022-09-05 9:55 pm By Cat Fredenburgh

Bangkok Broadcasting and Seven Networks have settled two lawsuits over the Thai broadcaster’s registration of ‘7’ marks in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Booktopia to pay $6M to settle ACCC case over refunds policy
Competition & Consumer Protection 2022-08-31 11:39 pm By Christine Caulfield

Online book retailer Booktopia has agreed to a $6 million penalty to resolve action brought by the consumer regulator alleging its refund policy was misleading.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

No jackpot for Aristocrat, with High Court split on computer-implemented inventions
High Court 2022-08-17 11:12 pm By Cindy Cameronne

Gaming giant Aristocrat Technologies has lost its legal challenge to a decision that rejected a patent for its popular Lightning Link electronic poker machine, after six High Court Justices were equally split on whether it could be patented.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Booktopia agrees on penalty in ACCC case over ‘misleading’ refund policy
Competition & Consumer Protection 2022-07-15 1:43 pm By Christine Caulfield

Booktopia has resolved a case by the consumer regulator alleging the online book retailer’s policy that required customers to request a refund within two business days of purchase was misleading.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Virgin moves to throw out ‘unintelligible’ lawsuit over COVID-19 jab mandate
COVID-19 2022-07-06 3:22 pm By Cindy Cameronne

Virgin Australia will seek to throw out a case brought by former employees over a COVID-19 vaccine mandate, which a lawyer for Qantas and Jetstar, which are also named in the suit, said “breaks every pleading rule”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Uniden found to have infringed radio design patent of rival GME
Intellectual Property 2022-05-23 3:29 pm By Sam Matthews

A judge has found that Uniden infringed rival GME’s design patent for a handheld radio, derailing the company’s plan for an Australian launch of two products.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pfizer sues drug companies over Enbrel biosimilar
Intellectual Property 2022-05-10 11:38 pm By Cat Fredenburgh

Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?